AJP - Heart AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 288: H2171-H2176, 2005. First published December 30, 2004; doi:10.1152/ajpheart.00427.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/5/H2171    most recent
00427.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Carvalho, F. C.
Right arrow Articles by Wajngarten, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Carvalho, F. C.
Right arrow Articles by Wajngarten, M.

Acute reduction of ventricular volume decreases QT interval dispersion in elderly subjects with and without heart failure

Francine C. de Carvalho, Fernanda M. Consolim-Colombo, Carlos Alberto Pastore, Marcelo C. Rubira, José Claudio Menegüetti, Eduardo Moacyr Krieger, and Mauricio Wajngarten

Heart Institute (InCor), Medical School, University of São Paulo, São Paulo, Brazil

Submitted 10 May 2004 ; accepted in final form 22 December 2004

To evaluate the effects of acute reduction in ventricular volume (VV) on QT interval dispersion (QTd), 14 men with heart failure (HF; 74.5 ± 2 yr of age) and 11 healthy male control subjects (68 ± 2 yr of age) were studied. For 15 min, lower body negative pressure (LBNP) was applied at –15 and –40 mmHg to reduce venous return. At baseline and during LBNP application, QTd was measured with an 87-lead, body-surface-mapping device; chamber volumes were assessed by radioisotope ventriculography; blood pressure (BP) and heart rate (HR) were continuously monitored; and blood samples were obtained for assessment of norepinephrine (Nor) levels. At –15 mmHg, LNBP application induced a significant decrease in VV but did not change BP and HR in both groups. In addition, Nor levels increased significantly (P ≤ 0.05) in the control group (from 286.7 ± 31.5 to 388.8 ± 41.2 pg/ml) and in HF patients (from 405.8 ± 56 to 477.6 ± 47 pg/ml), and QTd was significantly (P ≤ 0.05) decreased in the control group (57.2 ± 3.8 vs. 49.1 ± 3.4 ms) and in HF patients (67.8 ± 6 vs. 63.7 ± 5.9 ms). No additional decreases in VV or QTd were produced by –40 mmHg LNBP, but Nor levels did increase in both groups and reach 475.5 ± 34 and 586.5 ± 60 pg/ml (P < 0.05) in the control and HF groups, respectively; BP did not change, but HR also increased in both groups. In conclusion, an acute LBNP-induced reduction in VV caused a decrease in the QTd of elderly men regardless of the existence of HF. Because increased sympathetic activity with more intense LBNP was not accompanied by additional changes in QTd, altered QTd may be better related to changes in VV than to autonomic nervous system activity.

lower body negative pressure; cardiomyopathy; cardiac; norepinephrine; ischemic disease



Address for reprint requests and other correspondence: F. M. Consolim-Colombo, Hypertension Unit, Heart Institute (InCor), São Paulo, Brazil CEP 05403-000 (E-mail: hipfernanda{at}incor.usp.br)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.